how to be a good dog owner
how to be a good dog owner

Pet Advice from the Experts

When you have an inquisitive dog, danger comes from the least expected places, both in and out of the home. Read our latest blog articles and safety information to keep your dog happy and healthy to enjoy the Australian way of life.

Ear mites in dogs
Your guide to ear mites in dogs

While they are not life-threatening, ear mites in puppies and dogs can cause a great deal of irritation without effective treatment. Take an in-depth look at how to deal with them.

 

Read More
Ticks on dogs
Ticks on dogs: essential facts to keep your
dog safe

Ticks can cause serious and potentially fatal diseases in dogs. Read on to find out everything you need to know about ticks on dogs and how to keep your dog safe.

 

Read More
Mange on dogs
Mange on
Dogs
Symptoms,
Prevention
& Treatment 
Learn more about Mange on dogs
Roundworm in dogs
Roundworm
Symptoms,
Prevention & Treatment
Learn more about roundworms in dogs
Tapeworm
Symptoms,
Prevention & Treatment
Learn more about Tapeworms in dogs
Safety Profile

All medicines, including veterinary medicines, carry benefits and risks. NexGard® and NexGard SPECTRA® contain the active ingredient afoxolaner. Afoxolaner is part of the isoxazoline family of chemicals. Adverse reactions to this family of chemicals are rarely observed but may include vomiting, diarrhoea, lethargy, inappetence (loss of appetite), itching and very rarely, seizures. Most adverse reactions are mild, self-limiting and of short duration. For dogs with a history of epilepsy or other seizure disorders, it is recommended to seek veterinary advice prior to treatment with medicines of this class. Milbemycin oxime, the other active ingredient in NexGard SPECTRA, is part of the macrocyclic lactone family of chemicals. Adverse reactions to milbemycin oxime are rarely observed at recommended doses.

Rigorous safety studies demonstrate NexGard and NexGard SPECTRA’s excellent safety profile. This is further supported by Boehringer Ingelheim’s rigorous pharmacovigilance program which closely monitors and evaluates any suspected adverse events reported to the company by pet owners or veterinarians in all countries where the product is registered. 

For more information please read the product information leaflets .  If you have any questions or concerns about NexGard or NexGard SPECTRA, we encourage you to contact your Veterinarian or Boehringer Ingelheim Animal Health Customer Care directly on 1800 808 691.

Disclaimer

All content in this document is the property of Boehringer Ingelheim Animal Health Australia Pty. Ltd. and is protected by copyright. You may only use this document for informational, non-commercial, and personal use purposes. You may not modify this document, publish or commercially broadcast it in part or in full (including on a network computer) without our prior written consent. This notice must be retained in all circumstances. Copyright ©2021 Boehringer Ingelheim Animal Health Australia Pty. Ltd. ®NEXGARD SPECTRA, NEXGARD, HEARTGARD30 and PARAGARD are registered trademarks of the Boehringer Ingelheim Group. All rights reserved. PET-0102-2019. PET-0123-2021.